Jump to main content
eTG Complete
Index
Search
Home
Antibiotic
Directed therapy for bloodstream infections, including sepsis and septic shock
Staphylococcus aureus bacteraemia, including sepsis and septic shock
Duration of therapy for Staphylococcus aureus bacteraemia
Antibiotic
Bartonella infections
Osteomyelitis
Septic arthritis of a native joint
Bone and joint infections other than osteomyelitis and native joint septic arthritis
Sepsis or septic shock associated with a bone or joint source
Directed therapy for native bone or joint infection
Brucellosis
Infective endocarditis
Cardiovascular system infections other than endocarditis
Central nervous system infections
Coronavirus disease 2019 (COVID-19)
Cryptococcosis
Cytomegalovirus (CMV) infection
Infectious diarrhoea
Ear, nose and throat infections
Eye infections
Febrile neutropenia
Genital and sexually transmissible infections
Human immunodeficiency virus
Intra-abdominal infections
Leptospirosis
Lyme disease
Mediastinitis
Melioidosis
Mpox (monkeypox)
Nocardiosis
Nontuberculous mycobacterial infections
Oesophageal infections
Parasitic infections
Perinatal infections
Prevention of infection
Q fever
Pneumonia
Directed therapy for pneumonia
Respiratory tract infections other than pneumonia
Acute rheumatic fever
Rickettsial infections
Salivary gland infections
Sepsis and septic shock: Identification and initial management
Sepsis and septic shock: Empirical regimens
Directed therapy for bloodstream infections, including sepsis and septic shock
Modifying empirical therapy for bloodstream infections when the pathogen is identified
Candidaemia (including Candida and related species sepsis)
Enterobacterales (including E. coli and K. pneumoniae) bloodstream infections, including sepsis and septic shock
Pseudomonas aeruginosa bloodstream infections, including sepsis and septic shock
Staphylococcus aureus bacteraemia, including sepsis and septic shock
Approach to managing Staphylococcus aureus bacteraemia
Empirical therapy for Staphylococcus aureus bacteraemia
Directed therapy for Staphylococcus aureus bacteraemia
Duration of therapy for Staphylococcus aureus bacteraemia
Duration of therapy for S. aureus bacteraemia in adults
Duration of therapy for S. aureus bacteraemia in children
Assessing and monitoring patients with Staphylococcus aureus bacteraemia
Staphylococcal toxic shock syndrome
References
Streptococcus agalactiae (group B streptococcus) bloodstream infections, including sepsis and septic shock
Streptococcus pneumoniae (pneumococcal) bloodstream infections, including sepsis and septic shock
Streptococcus pyogenes (group A streptococcus) bloodstream infections, including sepsis, septic shock and toxic shock syndrome
Typhoid and paratyphoid fevers (Salmonella Typhi and Paratyphi A, B and C infection)
Skin and soft tissue infections
Traumatic wound infections
Urinary tract infections in adults
Urinary tract infections in children
Identifying resistant pathogens or Candida species
Principles of obtaining blood for culture
Principles of antimicrobial use
Antimicrobial stewardship (AMS)
Practical information on using antimicrobial drugs
Aminoglycoside use
Vancomycin use in adults
Vancomycin use in young infants and children
Monitoring antimicrobial blood concentrations
Ambulatory antimicrobial therapy
Antimicrobial hypersensitivity
Kidney impairment and antimicrobial dosing
Contact details for health departments and public health units
Amikacin initial dose calculator
Gentamicin initial dose calculator
Tobramycin initial dose calculator
Duration of therapy for Staphylococcus aureus bacteraemia
Duration of therapy for S. aureus bacteraemia in adults
Duration of therapy for S. aureus bacteraemia in children
